BENZALKONIUM CHLORIDE 0.13% and DRUG HYPERSENSITIVITY

Overview

DRUG HYPERSENSITIVITY is the #2 most commonly reported adverse reaction for BENZALKONIUM CHLORIDE 0.13%, manufactured by Meijer, Inc.. There are 116 FDA adverse event reports linking BENZALKONIUM CHLORIDE 0.13% to DRUG HYPERSENSITIVITY. This represents approximately 3.4% of all 3,369 adverse event reports for this drug.

Patients taking BENZALKONIUM CHLORIDE 0.13% who experience drug hypersensitivity should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DRUG HYPERSENSITIVITY is moderately reported among BENZALKONIUM CHLORIDE 0.13% users, representing a notable but not dominant share of adverse events.

Other Side Effects of BENZALKONIUM CHLORIDE 0.13%

In addition to drug hypersensitivity, the following adverse reactions have been reported for BENZALKONIUM CHLORIDE 0.13%:

• DRUG INEFFECTIVE — 124 reports
• CONDITION AGGRAVATED — 112 reports
• ARTHRALGIA — 110 reports
• THERAPY NON RESPONDER — 110 reports
• MUSCULOSKELETAL STIFFNESS — 108 reports
• PAIN IN EXTREMITY — 108 reports
• INFECTION — 107 reports
• HEPATOTOXICITY — 105 reports
• JOINT SWELLING — 105 reports
• MUSCULOSKELETAL PAIN — 105 reports

Other Drugs Associated with DRUG HYPERSENSITIVITY

The following drugs have also been linked to drug hypersensitivity in FDA adverse event reports:

Does BENZALKONIUM CHLORIDE 0.13% cause DRUG HYPERSENSITIVITY?

DRUG HYPERSENSITIVITY has been reported as an adverse event in 116 FDA reports for BENZALKONIUM CHLORIDE 0.13%. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DRUG HYPERSENSITIVITY with BENZALKONIUM CHLORIDE 0.13%?

DRUG HYPERSENSITIVITY accounts for approximately 3.4% of all adverse event reports for BENZALKONIUM CHLORIDE 0.13%, making it one of the most commonly reported side effect.

What should I do if I experience DRUG HYPERSENSITIVITY while taking BENZALKONIUM CHLORIDE 0.13%?

If you experience drug hypersensitivity while taking BENZALKONIUM CHLORIDE 0.13%, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages